Product Code: ETC131330 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Indonesia antidiabetics market is expected to witness healthy CARG in the future. Rising incidences of diabetes, increasing awareness about diabetes and its treatment, and growing investments in healthcare infrastructure are driving the growth of antidiabetic drugs in the country.
The growing prevalence of diabetes among people in Indonesia has led to an increase in demand for antidiabetic drugs over recent years. As per WHO estimates, around 10 million Indonesias suffer from type 2 diabetes (T2D). This is likely to drive the demand for antidiabetic drugs as individuals seek treatments that can control their blood sugar levels and reduce complications associated with T2D. Increasing awareness regarding lifestyle modifications and effective management strategies for controlling blood glucose levels could also be contributing to increased sales of antidiabetic products across Indonesia. Besides this, favorable government policies such as improved health insurance coverage have allowed more patients access to affordable medicines which has further boosted the demand for these drugs.
Limitations regarding the availability of oral hypoglycemic agents due to supply chain problems caused by a disruption in global logistics during the COVID-19 pandemic could impede the revenue growth of pharmaceutical companies operating within Indonesia`s antidiabetic drug industry. The presence Of counterfeit medications within Indonesia markets may lead to consumers being exposed to low-quality or substandard treatments resulting in more severe medical conditions leading to higher financial losses over time. Additionally, since most counterfeits cannot be differentiated from genuine medications without proper testing , it would result into lesser trust amongst customers towards branded manufacturers leading into lower sales potentials down the line.
Some key players operating within Indonesia`s Antidtibetic Drug Industry include Sanofi S A, Eli Lilly And Company, Novo Nordisk AS, Abbott Laboratories Inc., B Braun Melsungen AG, etc..
Indonesia Antidiabetics |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Antidiabetics Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Antidiabetics Market Revenues & Volume, 2020 & 2027F |
3.3 Indonesia Antidiabetics Market - Industry Life Cycle |
3.4 Indonesia Antidiabetics Market - Porter's Five Forces |
3.5 Indonesia Antidiabetics Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 Indonesia Antidiabetics Market Revenues & Volume Share, By Patient Population, 2020 & 2027F |
3.7 Indonesia Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
4 Indonesia Antidiabetics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Antidiabetics Market Trends |
6 Indonesia Antidiabetics Market, By Types |
6.1 Indonesia Antidiabetics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Antidiabetics Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Indonesia Antidiabetics Market Revenues & Volume, By Insulinย , 2018 - 2027F |
6.1.4 Indonesia Antidiabetics Market Revenues & Volume, By Drug Class, 2018 - 2027F |
6.2 Indonesia Antidiabetics Market, By Patient Population |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Antidiabetics Market Revenues & Volume, By Paediatric, 2018 - 2027F |
6.2.3 Indonesia Antidiabetics Market Revenues & Volume, By Adult, 2018 - 2027F |
6.2.4 Indonesia Antidiabetics Market Revenues & Volume, By Geriatric, 2018 - 2027F |
6.3 Indonesia Antidiabetics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2018 - 2027F |
6.3.3 Indonesia Antidiabetics Market Revenues & Volume, By Insulin pump, 2018 - 2027F |
6.3.4 Indonesia Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2018 - 2027F |
6.3.5 Indonesia Antidiabetics Market Revenues & Volume, By Oral, 2018 - 2027F |
6.3.6 Indonesia Antidiabetics Market Revenues & Volume, By Others, 2018 - 2027F |
7 Indonesia Antidiabetics Market Import-Export Trade Statistics |
7.1 Indonesia Antidiabetics Market Export to Major Countries |
7.2 Indonesia Antidiabetics Market Imports from Major Countries |
8 Indonesia Antidiabetics Market Key Performance Indicators |
9 Indonesia Antidiabetics Market - Opportunity Assessment |
9.1 Indonesia Antidiabetics Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 Indonesia Antidiabetics Market Opportunity Assessment, By Patient Population, 2020 & 2027F |
9.3 Indonesia Antidiabetics Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
10 Indonesia Antidiabetics Market - Competitive Landscape |
10.1 Indonesia Antidiabetics Market Revenue Share, By Companies, 2020 |
10.2 Indonesia Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |